Biotronik has announced the market release of Solia CSP S—the latest innovation in its growing portfolio of conduction system pacing (CSP) solutions. Solia CSP S is the “first and only” pacing lead worldwide that combines a fixed screw design with a stylet-driven implantation approach, offering physicians a new solution designed to simplify CSP procedures while enhancing control and precision, according to a press release from the company.
The first global commercial implants were successfully performed by Óscar Cano at the University and Polytechnic La Fe Hospital in Valencia, Spain.
“In my experience, the stylet-driven Solia CSP S together with the Selectra 3D catheter enabled good alignment with the septal wall and it was easy to penetrate the septum,” said Cano. “The procedures went very fast, and we had only minimal use of fluoroscopy.”
Biotronik claims that Solia CSP S uniquely combines the advantages of both fixed screw and stylet-driven designs, so physicians “no longer have to compromise”. The fixed screw design reduces preparation time while the stylet enables high steerability and continuous electrical measurements.
“The launch of Solia CSP S represents a step forward in making CSP procedures more accessible and efficient,” said Andreas Hecker, president of cardiac rhythm management (CRM) and electrophysiology (EP) at Biotronik. “It is part of our ongoing commitment to physiologic pacing and providing physicians with tools that streamline implantation for better patient outcomes.”
“The challenge in cardiac rhythm management today is to treat more patients while maintaining the highest standards of care,” added Joaquín Osca Asensi (La Fe Hospital, Valencia, Spain). “Tools like Biotronik’s CSP solution help us deliver physiologic pacing while keeping workflows lean and manageable.”
